1 Particulate and cytosolic protein kinase C (PKC) activity was measured in rat aortae with and without endothelium, following exposure to endothelin-1 (10-8 M) for various time intervals. 2 Endothelin-1 induced two peaks of particulate PKC activity, occurring at 30s and 10min exposure times in both endothelium-intact and endothelium-denuded preparations. Cytosolic PKC activity fell below baseline at all incubation times studied. 3 In endothelium-denuded preparations, elevation of guanosine 3':5'-cyclic monophosphate (cyclic GMP) levels with sodium nitroprusside (10-6M) or atrial natriuretic peptide (10-6M) and, in endothelium-intact preparations with the calcium ionophore A23187 (10-6M), inhibited the activation of particulate PKC activity seen after incubation with endothelin-1 for 30s. The inhibitory effect of A23187 was prevented by prior incubation of the endothelium-intact vessels with the nitric oxide synthetase inhibitor, L-NG-nitro arginine (5 x 10-s M). 4 These results indicate that EDRF acting via cyclic GMP can inhibit the activation of PKC induced by endothelin-1 in rat aorta. Keywords: Rat aorta; EDRF; protein kinase C; endothelin; L-N0-nitro arginine
IntroductionIn vascular smooth muscle, protein kinase C (PKC) is present in relatively high concentrations (Nishizuka, 1984) and is presumed to play an important role in the regulation of tone, particularly during the tonic phase of contraction (Rasmussen et al., 1987;Haller et al., 1990). Several constrictor agonists including endothelin have now been shown to cause activation and translocation of PKC from the cytosolic to the particulate fraction of vascular smooth muscle cells (Haller et al., 1990) and it has been shown that these events are responsible for the maintenance of tone during the tonic phase of contraction.Nitric oxide is now known to be the active principle of endothelium-derived relaxing factor (EDRF; Palmer et al., 1987). It induces vascular smooth muscle relaxation by the activation of soluble guanylate cyclase and elevation of intracellular levels of guanosine 3': 5'-cyclic monophosphate (cyclic GMP) (for review see Griffith et al., 1988). However, the precise mechanism whereby cyclic GMP induces smooth muscle relaxation is not fully understood. It is known that cyclic GMP inhibits phosphatidylinositol (PI) hydrolysis in vascular smooth muscle (Rapoport, 1986) and platelets (Takai et al., 1981). More recently it has been shown that in both vascular smooth muscle and endothelium this effect of cyclic GMP leads to inhibition of agonist-induced inositol 1,4,5-trisphosphate (1P3) production (Lang & Lewis, 1989;. However, this effect of cyclic GMP on IP3 production does not adequately explain the mechanism of inhibition of vascular smooth muscle tone during the tonic phase of contraction, which involves PKC activation.In the present study therefore we have investigated the effects of EDRF and other cyclic GMP elevating agents, on endothelin-1-induced activation of PKC in rat aorta.
Methods
Tissue preparationMale Wistar rats (250-300 g) ...